The increase in price target by a reputable analyst like Graig Suvannavejh from Mizuho is a strong positive signal for Harmony Biosciences. It suggests a bullish outlook on the company's future performance and potential growth, likely leading to increased investor confidence and a positive short-term impact on the stock price.